Status: Not yet recruiting
Neurocognitive Trajectories After BCMA CAR-T
The purpose of this research study is to evaluate cognitive changes over time in participants with relapsed or refractory multiple myeloma who have received chimeric antigen receptor T-cell therapy (CAR-T).
Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Wake Forest University Health SciencesUpdated: Jul 31, 2026Locations: 1
Eligibility criteria
Ability to understand and willingness to sign an IRB-approved informed consent [+8]
Active central nervous system (CNS) disease [+3]